APP and Alzheimer disease: In a cellular model of AD, Katsuda et al. showed that the transfer of sEVs from adipose tissue MSCs to N2A neuroblastoma cells, expressing both human APP and presenilin 2 mutations, causes a decrease in the levels of secreted and intracellular Aβ peptide [45].